Axon Enterprise, Inc.

(NASDAQ Global Select)
Back to all articles
Bullish +65

Axon Rises 23.3% in a Month: Should Investors Bet on the Stock Now?

AI-generated analysis

πŸ“ˆ AXON shares rose 23.3% in one month, outpacing the Zacks sub-industry and S&P 500.

πŸ’° Segmental revenues surged 32.8% year-over-year in Q1 2026, driven by TASER 10 adoption.

πŸ“± Software & Services ARR grew 35% in Q1 2026 due to expanding user base and digital evidence management.

🀝 Strategic partnership with TYTAN enhances Dedrone counter-drone capabilities against Group 3 threats.

πŸš‘ Acquisition of Carbyne enables the new Axon 911 integrated emergency response solution.

πŸ“ˆ Revenue growth guidance raised to 30-32% YoY for 2026, surpassing previous 27-30% estimates.

πŸ’΅ 2026 EPS estimate revised down slightly to $8.09 but still reflects 18.1% year-over-year growth.

πŸš€ 2027 EPS forecast stands at $10.68, indicating a projected 32% year-over-year increase.

βš–οΈ Stock trades at a forward P/E of 52.75X, higher than the industry average of 47.30X.

πŸ† Company holds Zacks Rank #1 (Strong Buy) with positive analyst sentiment and AI implementation focus.

Bullish Signals
  • Shares gained 23.3% in the past month, significantly outperforming peers like Teledyne Technologies and Kratos Defense.
  • Segmental revenues increased 32.8% year-over-year in Q1 2026, demonstrating strong product demand.
  • Software & Services annual recurring revenue (ARR) grew 35% in Q1 2026, reflecting high customer retention.
  • Revenue growth guidance for 2026 was raised to 30-32%, exceeding the earlier predicted range of 27-30%.
  • Strategic acquisition of Carbyne successfully launched the Axon 911 solution, expanding the product portfolio.
  • Partnership with TYTAN enhances counter-drone mitigation capabilities, opening new market sectors for Dedrone.
  • Earnings estimates for 2027 show a robust 32% year-over-year growth projection at $10.68 per share.
  • The company is well-positioned for the AI revolution with investments in implementation rather than just infrastructure.
Risk Factors
  • The stock trades at a forward P/E ratio of 52.75X, which is elevated compared to the industry average of 47.30X.
  • High valuation levels could make the stock vulnerable to further pullbacks if market sentiment sours.
Full Analysis
Axon Enterprise, Inc. (AXON) shares have surged 23.3% over the past month, significantly outperforming its Zacks sub-industry and the S&P 500. Trading at $486.12, the stock remains below its 52-week high but above its 50-day moving average. The company's growth is primarily driven by strong momentum in its Connected Devices segment, fueled by demand for next-generation TASER 10 products and cartridge revenues. Revenue performance has been robust, with segmental revenues surging 32.8% year-over-year in the first quarter of 2026, following a 29.1% increase in 2025. The Software & Services segment continues to expand due to increased user adoption and recurring revenue growth, which jumped 35% in Q1 2026 compared to the prior year. Strategic initiatives include partnerships with TYTAN for counter-drone capabilities and the acquisition of Carbyne to launch the Axon 911 solution. Analysts have revised earnings estimates upward, projecting approximately 30-32% year-over-year revenue growth for 2026, exceeding earlier predictions. Earnings per share are forecast at $8.09 for 2026 and $10.68 for 2027, indicating double-digit growth. Despite a forward P/E ratio of 52.75X, which is higher than the industry average, the stock holds a Zacks Rank #1 (Strong Buy) due to positive sentiment and robust growth prospects in AI, drones, and robotics.